the role of i-o in platinum-resistant recurrent oc
Published 5 years ago • 96 plays • Length 6:57Download video MP4
Download video MP3
Similar videos
-
6:57
case 4: i-o therapy for platinum-resistant recurrent disease
-
2:19
dr. moore on anticipated impact of the mirasol trial in platinum-resistant ovarian cancer
-
30:19
emerging opportunities in platinum-resistant recurrent ovarian cancer
-
6:54
adc in platinum-resistant ovarian cancer
-
14:46
managing platinum-resistant ovarian cancer
-
6:04
when to add bevacizumab for recurrent ovarian cancer
-
7:10
managing platinum-resistance and recurrent disease
-
1:09
dr. arend on unmet needs in platinum-resistant ovarian cancer
-
1:17:45
recurrent ovarian cancer (2023)
-
6:15
review of ovarian tumor types
-
25:20
ovarian cancer 2021: recent advance in treatment
-
2:20
dr. matulonis discusses niraparib/pembrolizumab combo in platinum-resistant ovarian cancer
-
5:41
bevacizumab’s role in recurrent ovarian cancer
-
3:25
ovarian cancer: recurrence after parp inhibition
-
2:28
dr. moore on the role of mirvetuximab soravtansine in ovarian cancer
-
6:15
the gog-0213 trial in recurrent ovarian cancer
-
6:28
case 4: treating platinum-resistant recurrent disease
-
4:07
expert approaches for treating recurrent ovarian cancer
-
5:27
recurrent ovarian cancer; considerations beyond the platinum-free interval
-
6:57
bevacizumab in platinum-resistant ovarian cancer
-
7:16
new options for recurrent ovarian cancer
-
9:08
factors in choice of treatment for recurrent ovarian cancer